<p>(A) Representative views of immunohistological staining of CD31 in HD group, RD group and PBS group (Scale bars: 150 µm). Number of CD31 positive vessels counted from immunohistological staining. Five views in each sample with three samples in each group were analyzed. (B) Expression of Ang-1, Tie-2, VEGF-A and VEGFR-2 analyzed by qRT-PCR. Each sample was repeated three times with three samples from each group. *p<0.05.</p
<p>Endothelial CD31 expression (red) marks blood vessels, PDGFRα in green and lipid membranes in gre...
<p>(A) CD34 immunohistochemistry was performed to evaluate angiogenesis in all samples. Diaminobenzi...
<p>(A) Western blots showing two representative samples per treatment group. (B) At day 21 post impl...
<p>a) Flow cytometric analysis of cell surface markers on expanded human VPC-derived VEGF-R2<sup>+</...
<p>CD31 was expressed in blood vessels, and the number of CD31-positive vessels (yellow arrow) was s...
<p>A) CD31 immunostaining in the ischemic boundary zone at different time points after cell transpla...
<p>(A) The implants were removed on day 14 after transplantation and were stained with anti human CD...
<p>A: Wound tissue in group 1 (implanted with untreated fibroblasts). B: Wound tissue in group 2 (im...
<p>(A). Morphometric analysis of endothelial density based on CD31 positive cells following implanta...
<p>Hematoxylin and eosin staining of grafts in (A) the vitrification-control group and (B) the LeIBP...
<p><b>(A)</b> Red-brown coloring was specified as positive staining. Original magnification100×. Sca...
<p>(a) Box-and-whisker plot comparing the stereologically assessed fractional blood vessel area betw...
<p>Tumors from the cell mixing experiments (n = 3) were evaluated to determine their composition. Su...
<p>Immunohistochemistry for (A;B) CD31 and (C–F) CD146 on (C;D) control and (E,F) experimental condi...
<p>(<b>A-1</b>) Representative images of PECAM-1-positive blood vessels at the lesion epicenter. Sca...
<p>Endothelial CD31 expression (red) marks blood vessels, PDGFRα in green and lipid membranes in gre...
<p>(A) CD34 immunohistochemistry was performed to evaluate angiogenesis in all samples. Diaminobenzi...
<p>(A) Western blots showing two representative samples per treatment group. (B) At day 21 post impl...
<p>a) Flow cytometric analysis of cell surface markers on expanded human VPC-derived VEGF-R2<sup>+</...
<p>CD31 was expressed in blood vessels, and the number of CD31-positive vessels (yellow arrow) was s...
<p>A) CD31 immunostaining in the ischemic boundary zone at different time points after cell transpla...
<p>(A) The implants were removed on day 14 after transplantation and were stained with anti human CD...
<p>A: Wound tissue in group 1 (implanted with untreated fibroblasts). B: Wound tissue in group 2 (im...
<p>(A). Morphometric analysis of endothelial density based on CD31 positive cells following implanta...
<p>Hematoxylin and eosin staining of grafts in (A) the vitrification-control group and (B) the LeIBP...
<p><b>(A)</b> Red-brown coloring was specified as positive staining. Original magnification100×. Sca...
<p>(a) Box-and-whisker plot comparing the stereologically assessed fractional blood vessel area betw...
<p>Tumors from the cell mixing experiments (n = 3) were evaluated to determine their composition. Su...
<p>Immunohistochemistry for (A;B) CD31 and (C–F) CD146 on (C;D) control and (E,F) experimental condi...
<p>(<b>A-1</b>) Representative images of PECAM-1-positive blood vessels at the lesion epicenter. Sca...
<p>Endothelial CD31 expression (red) marks blood vessels, PDGFRα in green and lipid membranes in gre...
<p>(A) CD34 immunohistochemistry was performed to evaluate angiogenesis in all samples. Diaminobenzi...
<p>(A) Western blots showing two representative samples per treatment group. (B) At day 21 post impl...